149 In vitro efficacy studies to support engineered T cell therapies

• Gemma Moiset,
• Sophie Vermond,
• Monique Hazenoot,
• Rene McLaughlin,
• Sabrina de Munnik,
• Marco Guadagnoli,
• Marijn Vlaming,
• Sann Holt

Affiliations

Gemma Moiset

1AIMM Therapeutics, Amsterdam, Netherlands

Sophie Vermond

Charles River Laboratories, Leiden, Netherlands

Monique Hazenoot

Charles River Laboratories, Leiden, Netherlands

Rene McLaughlin

Charles River Laboratories, Leiden, Netherlands

Sabrina de Munnik

Charles River Laboratories, Leiden, Netherlands

Marco Guadagnoli

Charles River Laboratories, Leiden, Netherlands

Marijn Vlaming

Charles River Laboratories, Leiden, Netherlands

Sann Holt

Charles River, Leiden, Netherlands